Jamie Dananberg
2020
In 2020, Jamie Dananberg earned a total compensation of $1.9M as Chief Medical Officer at Unity Biotechnology, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,167 |
|---|---|
| Option Awards | $438,054 |
| Salary | $442,020 |
| Stock Awards | $849,917 |
| Other | $11,400 |
| Total | $1,913,558 |
Dananberg received $849.9K in stock awards, accounting for 44% of the total pay in 2020.
Dananberg also received $172.2K in non-equity incentive plan, $438.1K in option awards, $442K in salary and $11.4K in other compensation.
Rankings
In 2020, Jamie Dananberg's compensation ranked 5,716th out of 13,090 executives tracked by ExecPay. In other words, Dananberg earned more than 56.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,716 out of 13,090 | 56th |
Division Manufacturing | 2,360 out of 5,620 | 58th |
Major group Chemicals And Allied Products | 944 out of 2,253 | 58th |
Industry group Drugs | 818 out of 1,953 | 58th |
Industry Pharmaceutical Preparations | 609 out of 1,458 | 58th |
Source: SEC filing on April 30, 2021.
Dananberg's colleagues
We found three more compensation records of executives who worked with Jamie Dananberg at Unity Biotechnology in 2020.